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Hematopoietic stem cells (HSCs) differentiate and generate all blood cell lineages
while maintaining self-renewal ability throughout life. Systemic responses to stressful
insults, either psychological or physical exert both stimulating and down-regulating
effects on these dynamic members of the immune system. Stress-facilitated division
and re-oriented differentiation of progenitor cells modifies hematopoietic cell type
composition, while enhancing cytokine production and promoting inflammation. Inversely,
stress-induced increases in the neurotransmitter acetylcholine (ACh) act to mitigate
inflammatory response and regain homeostasis. This signaling process is terminated
when ACh is hydrolyzed by acetylcholinesterase (AChE). Alternative splicing, which is
stress-modified, changes the composition of AChE variants, modifying their terminal
sequences, susceptibility for microRNA suppression, and sub-cellular localizations.
Intriguingly, the effects of stress and AChE variants on hematopoietic development
and inflammation in health and disease are both subject to small molecule as well as
oligonucleotide-mediated manipulations in vitro and in vivo. The therapeutic agents can
thus be targeted to the enzyme protein, its encoding mRNA transcripts, or the regulator
microRNA-132, opening new venues for therapeutic interference with multiple nervous
and immune system diseases.
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INTRODUCTION
Stress can be defined as a psychological, environmental, or phys-
iologic threat on homeostasis (Chrousos, 2009). Psychological
stress begins with impulses from high cortical centers via the
limbic system and results in the release of chemical mediators.
Catecholamine signals, and specifically, nor-adrenaline, are then
released from sympathetic nerve fibers in direct proximity to
target tissues assisting the body to launch a fight-or-flight reac-
tion, increasing heart rate, and blood flow to skeletal muscles
while decreasing immune reactions (Padgett and Glaser, 2003).
Another key contributor to these processes is the parasympathetic
neurotransmitter acetylcholine (ACh) which is fundamental for
nervous system function (Kaufer et al., 1998) and is also produced
by peripheral leukocytes (Kawashima and Fujii, 2000). These
two pivotal neurotransmitters are both up-regulated during stress
and can activate the hypothalamic-pituitary-adrenal axis (HPA)
and the sympathetic adrenal medulla (Black, 2002). Specifically,
sustaining moderate ACh levels is crucial for maintaining home-
ostasis: abrupt stress-induced elevation of ACh signaling may be
lethal whereas its gradual loss, as in Alzheimer’s disease, multi-
ple system atrophy, and other neuro-degeneration conditions, is
associated with progressive deterioration of cognitive, autonomic,
and neuromuscular functions (Soreq and Seidman, 2001). Also,
activation of cholinergic receptors is beneficial in pathological
states such as atherosclerosis, myocardial infarction, hypertensive
vasculopathy and nephropathy, and heart failure, largely due
to yet incompletely understood mechanisms (Chrousos, 2009;
McEwen and Gianaros, 2011). In our current review, we argue
that moderate ACh levels are also crucial for controlling immune
and inflammatory functions, both in the brain and in peripheral
tissues and that acetylcholinesterase (AChE) is a key contributor
toward sustaining these levels.
The dynamic hematopoiesis process of blood cell produc-
tion and differentiation is notably characterized by a continu-
ous turnover of cells throughout life. Hematopoietic stem cells
(HSCs) are characterized by their ability to generate all blood
cell lineages while maintaining self-renewal. These properties are
modified substantially when the host of these cells is exposed
to either psychological or physical stressors (Dudakov et al.,
2010), so that cells from the bone marrow and the vascular
marginal pool are rapidly mobilized to the circulation (Rafii et al.,
1995). Consequently, cytokines and chemokines capable of acti-
vating cells to immediately respond to various stimuli regulate
the production and longevity and determine the number of cir-
culating blood cells (Cavazzana-Calvo et al., 2011). Cytokines
further regulate the division and differentiation of progenitor cells
to develop into morphologically recognizable cells with distinc-
tive phenotype features. Myelopoiesis involves the production of
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granulocytes, monocytes, red blood cells (RBCs) and the platelet-
producing megakaryocytes (Mks). The lymphoid progenitor cells
can differentiate into T, B, or natural killer (NK) lymphocytes,
depending on the microenvironment. Importantly, mesenchymal
stem cells carry both nicotinic and muscarinic ACh receptors
(Hoogduijn et al., 2009). Stress-inducible changes in cholinergic
signaling and in any of these populations can hence drastically
modulate immune functions.
STRESS-AFFECTED HEMATOPOIESIS AND NEUROPOIESIS
There aremany interactions between the nervous and hematopoi-
etic systems. These include sequence and structural homology
between neuropoietic and hematopoietic factors. Neuropoietic
factors such as cholinergic differentiation factor (CDF) and ciliary
neurotrophic factor (CNTF) determine the developmental fate of
sympathetic neurons from noradrenergic to cholinergic function.
These show homologies to the hematopoietic cytokines granulo-
cyte colony-stimulating factor (G-CSF) and interleukin-6 (Bazan,
1991).
Hematopoietic factors may affect differentiation and regener-
ation of cholinergic neurons. In contrast, scopolamine, a mus-
carinic ACh receptor blocker, can abolish stress-induced erythro-
poiesis (Gol’dberg et al., 2000), and deficiencies of neuropeptides.
Substance P and calcitonin gene-related peptide (CGRP) lead
to a dramatic fall in neutrophil production; these neuropep-
tides stimulate bone marrow colony formation and affect neu-
trophils production via both direct and indirect effects on bone
marrow colony forming units of granulocyte/monocyte progeni-
tors (CFU-GM). The observed effects do not involve peripheral
blood CFU-GM, suggesting a direct neural control over BM
hematopoiesis (Broome et al., 2000). Furthermore, erythropoi-
etin was shown to exert neurotrophic and neuroprotective activ-
ities in different in vivo and in vitro models of brain damage as
well as an anti-apoptotic effect on microglia, the brain’s resident
immune cell (Vairano et al., 2002).
Hematopoietic factors may also affect differentiation and
regeneration of cholinergic neurons. In contrast, scopolamine, a
muscarinic ACh receptor blocker, can abolish stress-induced ery-
thropoiesis, and deficiencies of neuropeptides. Substance P and
CGRP lead to a dramatic fall in neutrophil production; these neu-
ropeptides stimulate bone marrow colony formation and affect
neutrophils production via both direct and indirect effects on
bone marrow CFU-GM progenitors. The observed effects do not
involve peripheral blood CFU-GM, suggesting a direct neural
control over BM hematopoiesis.
THE PARASYMPATHETIC SYSTEM ACETYLCHOLINE
HYDROLYZING ENZYME ACETYLCHOLINESTERASE
AND STRESS
The parasympathetic system and the ACh hydrolyzing enzyme
AChE together contribute to the delicate balance of hematopoi-
etic and immune events under stress (Figure 1). ACh produced
by the vagus nerve and/or by peripheral leukocytes (Rosas-Ballina
et al., 2011) can potently modulate several classical immune reac-
tions by activating the α7 nicotinic receptor α7nAChR on the
leukocytes’ membrane, which in turn blocks the NF-kB-mediated
production of pro-inflammatory cytokines such as IL-1 and
tumor necrosis factor (TNF) α. Compatible with this mechanism
of action, vagal stimulation suppresses septic shock-like response
after bacterial lipopolysaccharide (LPS) injection (Gol’dberg
et al., 2000; Tracey, 2002). Tissue residing mononuclear cells also
receive cholinergic signaling via ACh secreted from the vagus
and/or synthesized in these nucleated immune cells, which have
all the components of the cholinergic signaling system: ACh, the
ACh synthesizing enzyme choline acetyl-transferase (ChAT), and
the co-regulated vesicular ACh transporter VAChT, transcribed
from the same transcription unit, the ACh degrading enzyme
AChE and functional muscarinic and nicotinic ACh receptors.
Correspondingly, ACh receptors were identified on lymphocytes
from the thymus, lymph nodes, spleen, and peripheral blood
FIGURE 1 | Stress modifies AChE’s composition. Shown are the
N-terminal and C-terminal changes representing combinatorial differences
on AChE splice variants. The soluble monomeric AChE-R variant produced
in all tissues expressing this gene accumulates under stress and is found
in the circulation, albeit being less stable than AChE-S. Both AChE
variants are associated with stress-inducible hematopoiesis. The red-labeled
C-terminus of AChE-R represents the hematopoietic peptide ARP
[Grisaru et al. (2006)].
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(Tracey, 2002). Also, vagus nerve stimulation fails to inhibit TNF
α production in splenectomized animals during lethal endo-
toxemia, demonstrating cholinergic innervation of the spleen
(Huston et al., 2006).
In mice, peptidergic nerve fibers entering the bone mar-
row terminate with synapses on stromal and perivascular cells,
interactions thatwere implicated in local inflammationandregula-
tion of leukocyte trafficking (Gol’dberg et al., 2000). Endothelium,
a key regulator of leukocyte trafficking during inflammation, is
also a target of anti-inflammatory cholinergic mediators; both
vagus nerve stimulation and cholinergic agonists significantly
block leukocyte migration in vivo (Saeed et al., 2005). Cholinergic
neurons are also present in developing thymic rudiments and
their presence was associated with increased production of thymic
lymphocytes. The cholinergic system also affects HSCs and their
niche cells and plays an active role in T cell differentiation. Thus,
CD8+ T cells from M1 receptor-deficient mice fail to differen-
tiate into cytolytic T lymphocytes (Zimring et al., 2005). ACh
release from spleen T cells can in turn attenuate TNF α produc-
tion in spleen via α7nAChR expressed on innate immune cells
(Rosas-Ballina et al., 2010). Furthermore, T cells show plasticity
in their response to cholinergic stimuli, so that nicotine up-
regulates interferon-γ (IFN-γ) and down-regulates interleukin
(IL)-17 secretion, whereas muscarin enhances IL-10 and IL-17
and inhibits INF-γ secretion. As is implicated from the numerous
studies stated above, ACh signaling is essential for T-cell activa-
tion and its opposite function may be required to synchronize
and balance ionic and metabolic events in a single lymphocyte.
Within the T-cell, the ACh regulatory axis may provide for a fine
tuning of the T cells to changing environment (Qian et al., 2011).
In all peripheral tissues, ACh signals normally remain above
a certain threshold sufficient to suppress the production of pro-
inflammatory cytokines, yet are transiently reduced following
stress due to AChE over-production which lasts several hours
(Nance and Sanders, 2007). Within 24 h, elevation of the AChE-
targeted microRNA-132 (Shaked et al., 2009; Soreq and Wolf,
2011) reduces AChE levels, retrieving ACh-mediated block-
ade of pro-inflammatory cytokines production. Therefore, stress
responses also facilitate yet more IL-1 production (Gilboa-Geffen
et al., 2007). Monocytes, macrophages, dendritic cells, and T
lymphocytes which infiltrate peripheral organs and accelerate
pathological processes are exposed to the adrenergic and cholin-
ergic transmitters released by the autonomic innervations of these
organs, which could dramatically alter cytokine release (Nance
and Sanders, 2007). That serum AChE activity continuously
increases with age (Sklan et al., 2004) may suggest aging-related
deterioration in the efficacy of this regulation process.
Under stress, the elevated glucocorticoid cortisol interacts
with two cytosine/guanosine (CpG-rich) sequence motifs in the
AChE promoter to induce nuclear transcriptional and post-
transcriptional events of over-production of AChE and replace
the major stable AChE splice variant AChE-S by the less sta-
ble AChE-R variant (Figure 2) (Meshorer et al., 2002). This
effect associates with release from AChE-R of the cleavable C-
terminal peptide ARP. Both AChE-R and ARP can stimulate
the proliferation of CD34+ hematopoietic progenitor cells and
facilitate the proliferation and differentiation of promegakary-
ocytes and subsequent platelet production (Pick et al., 2006).
When secreted, the extra-cellular AChE-R hydrolyzes ACh as
efficiently as AChE-S, further facilitating the production of
pro-inflammatory cytokines; and when retained in the intra-
cellular space AChE-R interacts through the C-terminal ARP
peptide with several partner signaling proteins, also promot-
ing cell proliferation (Meshorer et al., 2005). Ex vivo, ARP
was more effective than cortisol and equally effective as stem
cell factor in promoting expansion and differentiation of early
FIGURE 2 | AChE controls the anti-inflammatory reflex. (A) At the
extracellular space, both AChE-S and AChE-R hydrolyze ACh, impairing its
capacity to block, through the α7 nicotinic ACh receptor, the activation of
NFκB which enables pro-inflammatory cytokine secretion (the so-called
“anti-inflammatory reflex”). (B) Under normal conditions, AChE-S is by
far the prominent variant keeping ACh in balance, AChE-R being the
soluble, minor component. (C) Under stress, excess ACh impairs the
cholinergic balance. (D) Substitution of AChE-S with excess AChE-R
facilitates ACh hydrolysis, shifting the imbalance to AChE excess
[Ofek et al. (2007)].
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hematopoietic progenitor cells into myeloid and Mk lineages
(Pick et al., 2006).
Tissue macrophages are effectively deactivated when exposed
to ACh, suppressing the release of the pro-inflammatory
cytokines TNF-α, IL-1β, and IL-18 at the post-transcriptional
level (Tracey, 2002). Among other effects, immune stimuli induce
over-expression of the AChE-targeting microRNA-132 in leuko-
cytes (Soreq and Wolf, 2011). Consequently, microRNA-132
reduces AChE levels, increasing the available ACh and finally
inhibiting the secretion of pro-inflammatory cytokines (Wang
et al., 2003). Inversely, mice engineered to over-express a 3′-
shortened and hence microRNA-132 refractory AChE-R present
excessive leukocyte recruitment into the peritoneum, higher
levels of inflammatory cytokines than strain-matched controls
and impaired cholinergic anti-inflammatory regulation in spite
of substantial microRNA-132 up-regulation both in the bone
marrow and the hypothalamus. Intravenous injection to wild-
type mice of an LNA-modified anti-miR-132 oligonucleotide
increases AChE activity in the bone marrow, spleen, and serum,
with parallel consequences (Shaked et al., 2009). MiR-132 has
been shown to be a regulator of neuronal structure and func-
tion. Transgenic mice over-expressing miR-132 in forebrain neu-
rons display increased dendritic spine density and decreased
expression of MeCP2, a protein implicated in Rett Syndrome
and other disorders of mental retardation. These mice dis-
played significant deficits in novel object recognition (Hansen
et al., 2010). However, shRNA-mediated suppression of the
“synaptic” AChE-S variant prevented the increase in miR-132
following footshock stress, suggesting bidirectional regulation
(Shaltiel et al., in press).
Furthermore, miR-132 has been shown to be induced during
periods of active synaptogenesis and is necessary and sufficient
for hippocampal spine formation. Knockdown of the miR-132
target p250GAP increases spine formation while overexpression
attenuates this activity (Impey et al., 2010).
AChE AND GRANULOCYTOSIS
AChE-R and ARP both induce granulocytosis (Grisaru et al.,
2001). The specificity of ARP is supported by the finding that
ASP, the parallel yet distinct C-terminal peptide of AChE-S, fails
to induce such effects (Figure 3). In the post-partum human
serum, AChE-R excess was speculated to lead to reduced ACh
concentrations. AChE-R accumulation might hence be perceived
as an adaptive response, facilitating the production of pro-
inflammatory cytokines to protect the body from post-partum
conditions, such as infections. This is compatible with obser-
vations of increased production of pro-inflammatory cytokines
under stress and further proliferative and cell activation signals
(Broome et al., 2000). Protracted post-stress granulocytosis ini-
tiated by cortisol would then increase AChE-R production and
reduce ACh’s anti-inflammatory action.
Subsequent secondary feedback response to the initial excess
of ACh and AChE in the periphery is needed to re-balance
parasympathetic activities (Erb et al., 2001), suppress the pro-
duction of pro-inflammatory cytokines in macrophages (Tracey,
2002), and terminate the granulocytosis process. Such responses
can potentially involve changes in miR-132 which can suppress
AChE activities. In contrast, IL-1β induces ACHE gene expres-
sion in phaeochromocytoma cells (Li et al., 2000) (Figure 4). The
involvement of AChE-R in immune system activities under acute
FIGURE 3 | AChE variants exert hematopoietic effects through
common and distinct protein partners. (A) The common core
domain of AChE interacts with laminin. (B) To validate partner interactions,
the C-termini of AChE-S and AChE-R were constructed together with GFP.
(C) The C-terminus of AChE-S interacts with the anti-apoptogenic nuclear
CtBp, whereas intracellular AChE-R interacts with the proliferation
activating scaffold PKCβ carrier RACK1 and with Enolase.
(D) Fluorescent cell images: GFP constructs direct the AChE-S and
AChE-R C-termini to nucleus and cytoplasm, respectively
[Perry et al. (2007)].
Frontiers in Molecular Neuroscience www.frontiersin.org March 2012 | Volume 5 | Article 30 | 4
Gilboa-Geffen et al. Stressing hematopoiesis
FIGURE 4 | AChE splice variants induce inverse hematopoietic effects.
(A) The AChE gene and its S and R transcripts. (B) The hematopietic pathway
(black arrows).Up and down changes in cell compositions are presented as
red and blue arrows for transgenic excess in AChE-R (red) and AChE-S (blue).
(C) Scheme: Inverse outcome and the proteins involved [Gilboa-Geffen et al.
(2007)].
stress further prolongs the beneficial (pro-inflammatory) HPA
effects mediated through cortisol. While explaining the harm-
ful aspects of stress (chronically high cytokine levels) (Grisaru
et al., 2001), increased levels of AChE-R can also maintain the
immune system at high alert, avoiding acute suppression of
the immune system and providing protection from bacterial
infection.
THE AChE-S SPLICE VARIANT CAUSES LEUKOPENIA
AChE gene expression increases during apoptosis (Zhang et al.,
2002), and silencing of the AChE gene by small interference (si)
RNA prevents apoptosis (Pick et al., 2006). Given that AChE-S
is by far the major AChE splice variant in all tissues (Soreq and
Seidman, 2001), this suggests that AChE-S induces apoptosis,
alternatively or additionally to its known role in the apoptosome
formation. One possible mechanism through which this could
occur involves the interaction of AChE-S with the anti-apoptotic
C-terminal binding protein (CtBP). Supporting this notion,
AChE-S excess capable of blocking the anti-apoptotic effect of
CtBp reduces T lymphopoiesis and thrombopoiesis, inversely
to the effect of AChE-R, which up-regulates hematopoiesis
(Gilboa-Geffen et al., 2007). Correspondingly, AChE-S over-
expressing mice (TgS) present elevated hemoglobin and total
RBC counts accompanied by decreased platelet counts, GR1 +
myeloid cells and T lymphocytes [both T helper (CD4+) and
T suppressor cells (CD8+)], but unchanged content of mono-
cytes (CD11b+) and B lymphocytes (CD19+) (Perry et al., 2007).
This suggests that the CFU-GEMMprogenitor cells from AChE-S
over-expressing mice preferentially differentiate toward erythro-
poiesis rather than megakaryocytopoiesis and granulopoiesis,
inverse to the stress-induced enhancement of granulopoiesis and
thrombocytosis, under AChE-R over-expression (Grisaru et al.,
2001). Together, under acute stress (Gilboa-Geffen et al., 2007;
Perry et al., 2007), elevated AChE-R and decreased AChE-S levels
can, therefore, induce a bimodal myelopoietic and thrombopoi-
etic effect: first, by increasing AChE-R inducing proliferation,
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and second by enhancing the CtBP-anti-apoptotic effect due to
AChE-S loss which releases CtBP from AChE/CtBP complexes
(Figure 4).
STRESS-INDUCED THROMBOPOIESIS
Thrombopoiesis increases in response to stress-increased produc-
tion of AChE-R. This likely involves AChE-R interaction with the
scaffold protein RACK1 and its cargo PKCε (Perry et al., 2007),
which induces megakaryocytic differentiation in HEL and K562
cells and in primary humanHSCs (Lev-Lehman et al., 1997). TPO
and platelet counts also increase in the AChE-R overproducing
TgR mice as compared to the strain-matched control mice. This
affects the non-fatal LPS response: LPS administration (5 ug/kg)
induces a rapid fall in platelet counts in both TgR and control
mice, but platelet and WBC recovery is considerably faster in TgR
mice, likely due to the increased capacity of TgR BM progeni-
tors to proliferate and differentiate into pluripotent CFU-GEMM,
CFU-GM, and CFU-Mk (Pick et al., 2006; Perry et al., 2007).
Moreover, thrombopoietin (TPO) increases PKCε expression in
mouseMks, whereas blocking PKC activation inhibits platelet for-
mation (Deutsch et al., 2002). Thus, the elevated levels of TPO,
AChE-R, and PKCε in plasma and Mks from TgR mice support
the notion of a cholinergic promotion of thrombopoietic signal
transduction both through the hydrolytic and the non-enzymatic
features of AChE-R. The pivotal role played by AChE-R and ARP
in hematopoiesis and thrombopoiesis suggests a potential new
strategy for improving post-engraftment thrombopoiesis.
STRESS AND THYMOCYTE DEVELOPMENT
In the autoimmune disease Myasthenia gravis (MG) AChE-R
translocates to the membrane-associated fraction of thymocytes,
reflecting the activation state of the thymic cells. Like thymus
from MG patients, the thymus from TgR mice displays an
abnormally high number of immature thymocytes compared to
control mice. PKCβII which plays a role in B cell receptor survival
signaling (Oshevski et al., 1999) is also over-expressed in TgR
mice compared to FVB/N controls. AChE-R could thus protect
immature thymocytes from apoptosis, maintaining a high level of
the anti-apoptotic protein Bcl-2 (Rojnuckarin and Kaushansky,
2001). The high number of thymocytes in TgR mice is compati-
ble with production of AChE-R by cortical stromal cells exerting
a protective signal from apoptosis to the neighboring thymocytes.
That immature thymocytes located in the cortex require con-
tact signals with the cortical epithelium to survive (Toiber et al.,
2008), may therefore, explain why excessive AChE-R production
by cortical stromal cells induces an efficient positive selection
process in the TgR thymus. Also, AChE-R could be produced
by the thymocytes themselves, and thymocytes cultured from
TgR mice are more resistant to apoptosis than normal thymo-
cytes, even in the absence of stromal cells. Cholinergic signals
and AChE’s catalytic activity thus influence thymocytic apopto-
sis in inverse directions, so that the pro-apoptotic effect of ACh
is counterbalanced by a proliferative effect that could be pre-
dominant for the AChE-R variant. Supporting this notion, the
TgR thymus presents more proliferating cells (expressing the Ki67
antigen) compared to control mice (Gilboa-Geffen et al., 2007)
(Figure 5).
STRESS, AChE SPLICE VARIANTS AND ANTISENSE
MODULATION
Antisense oligonucleotides are short synthetic strands of mod-
ified DNA or RNA designed to hybridize within the cell with
target-specific mRNA by Watson–Crick base pairing. Binding
activates RNAses that degrade them. RNA–antisense complexes
block synthesis of the protein encoded by the mRNA sequence
and release the antisense agent to bind to a further strand
of mRNA, creating a recycling antisense mechanism. An anti-
sense agent which selectively destroys AChE-R, EN101 (cur-
rently denoted BL-7040) is a 20-mer oligonucleotide, chemically
modified by incorporating 2′oxymethyl groups in the last three
nucleotides at its 3′ end. EN101/BL-7040 binds to a coding
sequence common to all splice variants of human AChE (Evron
et al., 2005). Since the AChE-R mRNA transcript includes less
guanosines and cytosines than AChE-S, it is intrinsically less sta-
ble and more sensitive to this treatment. BL-7040/EN101 is an
FDA approved orphan drug shown to be safe for human use and
active both intravenously and orally in the suppression of the
progressive muscle fatigue symptoms of rats with experimental
myasthenia gravis (MG), an autoimmune neuromuscular disease
involved with systemic AChE-R over-production (Brenner et al.,
2003). It was also demonstrated to suppress AChE-R in primates
(Evron et al., 2005) and in human myasthenic patients (Argov
et al., 2007; Sussman et al., 2008).
Other short oligonucleotides, designated aptamers can be
selected to tightly and specifically bind a target protein molecule
(Que-Gewirth and Sullenger, 2007) and have been approved for
the therapeutic use by the US FDA. A 50-mer nuclease-resistant
RNA aptamer with 2′-amino-modified pyrimidines can recog-
nize human muscarinic AChR, and cross-react with MG patient
autoantibodies (Lee and Sullenger, 1997), efficiently preventing
them from down-modulating AChR expression on human cells
(Que-Gewirth and Sullenger, 2007). Intriguingly, BL-7040 also
operates as an aptamer activator of Toll-like receptor 9 (TLR9)
facilitating an alternative route of NFκB, controlling salivary
function (Gilboa-Geffen et al., 2011) and avoiding post-traumatic
stress in mice exposed to predator scent (Zimmerman et al.,
2012).
STRESS AND NEUROIMMUNE SIGNALING
Within the central nervous system, neuronal ACh levels rapidly
increase under stress, followed by a feedback response of AChE
overproduction which can tilt the balance to reduce ACh levels
(Kaufer et al., 1998). Correspondingly, the key pro-inflammatory
mediator IL-1 is over-expressed in the brain under stress. That
IL-1 can induce neuronal AChE synthesis (Li et al., 2000)
would further suppress ACh levels, inducing a feed-forward loop
of stress-inducible inflammatory response in the brain. This
response is pivotal for those neural systems thought to be involved
in stress effects in PTSD in humans (Rauch et al., 2006) and in
predator stress effects in animals (Adamec et al., 2005). Systems
implicated include the amygdala, hippocampus, and medial pre-
frontal cortex and brain stem targets of forebrain limbic systems.
It is unlikely that within such complex circuitry, changes in one
system are responsible for all lasting effects of stress. Nevertheless,
neuronal AChE-R has been found to be functionally involved in
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FIGURE 5 | AChE-R potentiates lymphopoiesis and
megakaryopoiesis. Excess of the stress-induced AChE-R variant
induces thymocytes hyperproliferation, compatible with the clinical
phenotype in myasthenic patients, as well as thrombopoiesis.
This reflects on myasthenia gravis where antisense suppression
of AChE-R was effective in phase I clinical trials [Argov et al. (2007)].
Below: Megakaryoblasts (Meg-01) cells scanned by electron micrographs.
Control Meg-01 cells exhibit a smooth surface. Cells treated for 24 h with
ARP show initial formation of flat membrane
sheets (middle panels) or elongated pseudopodia reflecting
proplatelet formation territories (right panels) characteristic
of megakaryocytic differentiation [Guimaraes-Sternberg et al. (2006)].
stress-mediated facilitation of fear learning, limbic neural plastic-
ity, and change in affect in predator stress (Adamec and Shallow,
1993; Nijholt et al., 2004; Adamec et al., 2008). Specifically, stress-
induced transcription of AChE-R facilitates neuroplasticity in
the brain’s limbic structures, resulting in long-lasting changes in
neural systems (Meshorer et al., 2002; Nijholt et al., 2004).
Severe stress may precipitate affective disorder lasting up to
a life time after traumatic stress (Yehuda, 2002). Predator stress
(inescapable and unprotected exposure to a cat) likewise lastingly
increases rodent anxiety (Adamec and Shallow, 1993). Increased
expression of AChE-R following stress has been demonstrated
in some of the same areas involved in predator stress-induced
limbic neuroplasticity, including the hippocampus and amyg-
dala. Intriguingly, BL-7040/EN101 administration limits these
stress reactions. Predator stress abnormally increases the tran-
scription of AChE-R, which in turn alters the neural substrate
responsible for the changes in acoustic startle amplitude. BL-
7040/EN101 reduces the mRNA for AChE-R, and prevents the
occurrence of these changes (Adamec et al., 2008). This effect
involves TLR9 activation and is preventable by the TLR9 block-
ing oligonucleotide ODN 2088 (Zimmerman et al., 2012). It has
been proposed that following severely stressful events, AChE-R
increases to a level which is no longer adaptive and results in phys-
iological changes which contribute to changes in affect observed
in post-traumatic stress disorder (PTSD) (Meshorer et al., 2002;
Nijholt et al., 2004). Correspondingly, systemic administration
of BL-7040/EN101 selectively lowers the level of AChE-R both
peripherally (Argov et al., 2007) and in the brain (Evron et al.,
2005; Pollak et al., 2005). In view of the TLR9 involvement,
this effect indicates inter-related coordination between the innate
immune system and the AChE gene expression. Termination of
the granulocytosis response in the periphery thus resembles the
termination of stress-inducible neurotransmission in the brain,
highlighting the close inter-relationships between the neuronal
and immune cell reactions to stress (Kiecolt-Glaser et al., 2003).
NON-CATALYTIC ROLE FOR AChE IN THE CNS
The stress-related role of neural AChE was inferred from exper-
iments in which over-expression of AChE-R mRNA was sup-
pressed in mice subjected to closed head injury by administration
of mouse/EN101 (Shohami et al., 2000). This treatment reduced
the number of dead neurons and facilitated neurologic recovery,
suggesting that AChE-R and/or secondary element(s) induced by
overexpression of AChE-R contributed to neuronal death (Metz
and Tracey, 2005). This could reflect a direct contribution of the
increased hydrolytic capacity of the induced AChE to reduce the
tissue level of ACh, promoting inflammation and tissue damage.
Alternatively, or in addition, stress-induced AChE could selec-
tively contribute to cellular apoptosis through its non-catalytic
properties, inducing cell death in non-cholinergic neurons as well
(Zhang et al., 2002; Park et al., 2004).
Photoreceptor loss is the primary cause of blindness in degen-
erative diseases such as retinitis pigmentosa and age-related
macular degeneration. Exposure of albino rats to bright light
provides an established model for photoreceptor damage and
stress-induced photoreceptor injury (Stone et al., 1999). A variety
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of growth hormones, cytokines (LaVail et al., 1992), and antiox-
idants (Organisciak et al., 1992) were found to partially protect
retinal photoreceptors from light damage, suggesting causal
involvement of stress-induced processes. The importance of AChE
gene expression for retinal maintenance was experimentally val-
idated in a detailed neuro-anatomic survey that demonstrated
impaired formation of the inner retina and degeneration of pho-
toreceptors in an AChE knockout mouse where ALL of the AChE
variants are missing (Bytyqi et al., 2004). The major excitatory
neurotransmitter of the retina is L-glutamate, whereas ACh plays
a limited role in visual information processing within the retina
and is found mainly in amacrine and ganglion cells in the prox-
imal part of the retina (Hutchins, 1987; Criswell and Brandon,
1993). Either AChE-S or AChE-R can appear either with a cleav-
able N-terminal signal peptide or with an extended N terminus,
potentially making it membrane bound. AChEmRNA expression
in human adult photoreceptors (Broide et al., 1999), cells that
are not involved in cholinergic synaptic activity further raises
the possibility that AChE in photoreceptors exerts stress-related
morphogenic function(s). It was shown that the N-AChE protein
plays a detrimental role, exacerbating photoreceptor injury after
exposure to bright, damaging light. Notably, EN101 treatment
limited light-induced damages to the retina (Kehat et al., 2007).
Future experiments are needed to find out whether N-AChE-R
accumulates in retinal (and other) neurons after other stressful
episodes such as increased pressure (glaucoma), metabolic stress
(diabetes), and ischemia, where it may play detrimental role(s)
promoting neuronal and specifically retinal damage.
CONCLUDING REMARKS
To properly function, the immune system depends on a fine-
tuned balance of immune cell activation, proliferation, and
differentiation which is perturbed under stress. Consequently,
hematopoietic and immune responses are largely modified under
stress in an inter-related manner conserved throughout evolu-
tion. First, stress inducible changes in hematopoietic processes
can substantially modulate both the immune and CNS functions,
for example, by over-producing cytokines which can penetrate
the brain and affect neuronal activities. Second, the parasympa-
thetic system, largely through AChE modulations, contributes to
the delicate balance between hematopoietic and immune events
and CNS reactions under stress. The major AChE splice variant
AChE-S is replaced by the stress-induced AChE-R variant. Due
to modified splicing, consequently impaired AChE-S-CtBp inter-
action as well as enhanced AChE-R-RACK1 interactions, both
enhance granulopoiesis and thrombocytosis. Increased levels of
AChE-R can thus trigger beneficial resistance to acute overstimu-
lation under exposure to microbial molecules such as LPS, but
at the same time sustaining the harmful effects of chronically
high cytokine levels. This balance of stress-inducible positive and
negative effects can be maintained by diverse Oligonucleotide
treatments, achieving better control over both nervous system
and immune functions. While these therapeutic strategies await
further studies to discern the corresponding molecular mech-
anisms, the promising findings can already point at numerous
previously unforeseen interactions between the immune and the
nervous system.
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